Pediatric Perfusion Systems Market - By Product (Oxygenators, Cannulas and Catheters, Blood Pumps, Arterial Filters), By Application (Cardiac Surgeries, Organ Transplantation), By End-use (Hospitals, Cardiac Centers)

Description

List of Tables

Pediatric Perfusion Systems Market is projected to register a CAGR of over 6.8% between 2023 and 2032, owing to the advancements in pediatric cardiac surgeries and interventions. The rising prevalence of congenital heart defects among children and the need for precise & tailored perfusion during pediatric cardiac procedures contribute significantly to the market expansion. As per World Heart Federation, in August 2023, one in every 100 children born around the world, suffer from congenital heart disease (CHD). Approximately half of the children with CHD needed a medical intervention in their lifetime.

Furthermore, continuous investment by manufacturers in developing perfusion systems with enhanced features, such as miniaturization, improved biocompatibility, and advanced monitoring capabilities drive the product demand. These technological advancements not only address the physiological challenges of pediatric patients but also contribute to the overall safety and efficiency of pediatric perfusion procedures.

The overall pediatric perfusion systems market is segmented based on product, application, end-use, and region.

Pediatric arterial filters segment is poised to generate notable revenues over the forecast period, backed by safety and efficacy offered by these products. With growing awareness regarding the unique challenges posed by pediatric patients during cardiac surgeries, there is a heightened focus on specialized equipment, such as arterial filters, designed to ensure optimal blood purification and oxygenation. These filters are gaining prominence for their ability to provide effective removal of microemboli and debris during pediatric cardiopulmonary bypass procedures, thereby minimizing the risk of complications.

Organ transplantation segment is slated to witness significant growth during 2023-2032, favored by meticulous and tailored perfusion support during organ harvesting and transplantation procedures. Pediatric perfusion systems, designed specifically for the unique physiological needs of children, offer advanced features ensuring optimal organ preservation and viability. As the procedures for organ transplantation in the pediatric population rises, healthcare providers continuously favor specialized perfusion systems that can provide precise oxygenation, temperature control, and circulatory support.

Asia Pacific pediatric perfusion systems industry is expected to generate lucrative opportunities and expand at a modest rate over 2023-2032. Rapid economic development, coupled with advancements in healthcare infrastructure, leads to an increased focus on pediatric cardiac care, creating a robust demand for specialized perfusion systems. Moreover, the rising pediatric population, contributes to a surge in pediatric cardiac surgeries and interventions. The growing awareness among healthcare professionals about the importance of tailored perfusion systems for pediatric patients further stimulates the regional market expansion.

Product Code: 7499

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & working
1.3 Data collection
1.4 Base estimates & workings
1.5 Forecast calculations
1.6 Data Sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Global pediatric perfusion systems market 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Regional trends
- 2.1.3 Product trends
- 2.1.4 Application trends
- 2.1.5 End-use trends

Chapter 3 Pediatric Perfusion Systems Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing pediatric cardiovascular surgeries
  - 3.2.1.2 Increasing advancements in perfusion technology
  - 3.2.1.3 Growing pediatric population coupled with early disease diagnosis
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of pediatric perfusion systems
  - 3.2.2.2 Complexity in pediatric surgeries
3.3 Growth potential analysis
- 3.3.1 By product
- 3.3.2 By application
- 3.3.3 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6 Technological landscape
- 3.6.1 3D printing in pediatric perfusion
- 3.6.2 Data analytics and artificial intelligence (AI)
3.7 Reimbursement policies
3.8 Procedural volume, by application, 2018-2022
3.9 Porter's analysis
3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company market share analysis, 2022
4.4 Competitive analysis of major market players, 2022
4.5 Competitive positioning matrix, 2022
4.6 Strategy dashboard, 2022

Chapter 5 Pediatric Perfusion Systems Market Size and Forecast, By Product, 2018-2032 (USD Million)

5.1 Key trends, by product
5.2 Pediatric oxygenators
5.3 Pediatric cannulas and catheters
5.4 Pediatric blood pumps
5.5 Pediatric arterial filters
5.6 Monitoring systems
5.7 Other products

Chapter 6 Pediatric Perfusion Systems Market Size and Forecast, By Application, 2018-2032 (USD Million)

6.1 Key trends, by application
6.2 Cardiac surgeries
6.3 Organ transplantation

Chapter 7 Pediatric Perfusion Systems Market Size and Forecast, By End-use, 2018-2032 (USD Million)

7.1 Key trends, by end-use
7.2 Hospitals
7.3 Cardiac centers
7.4 Other end-users

Chapter 8 Pediatric Perfusion Systems Market Size and Forecast, By Region, 2018-2032 (USD Million)

8.1 Key trends, by region
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East & Africa

Chapter 9 Company Profiles

9.1 Medtronic
9.2 LivaNova PLC
9.3 Terumo Cardiovascular Systems Corporation
9.4 BL Lifesciences
9.5 Cardinal Health
9.6 EUROSETS
9.7 Getinge AB
9.8 Nonin
9.9 Edwards Lifesciences Corporation
9.10 Stryker Corporation